
First-in-Humans Study of the SSTR Antagonist 177Lu-DOTA-LM3 for Peptide Receptor Radionuclide Therapy in Patients with Metastatic Neuroendocrine Neoplasms
Nuclear medicine has entered an era when we are discovering more and more molecules which can precisely target cancer cells. In this case, the molecule